Cellebrite DI Ltd. (FRA:9W9)

Cellebrite DI Statistics

Total Valuation

Cellebrite DI has a market cap or net worth of EUR 2.73 billion. The enterprise value is 2.30 billion.

Market Cap	2.73B
Enterprise Value	2.30B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	244.47M
Shares Outstanding	n/a
Shares Change (YoY)	+19.30%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	123.06M

Valuation Ratios

The trailing PE ratio is 40.93 and the forward PE ratio is 23.25.

PE Ratio	40.93
Forward PE	23.25
PS Ratio	6.74
PB Ratio	6.62
P/TBV Ratio	11.32
P/FCF Ratio	20.00
P/OCF Ratio	18.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.96, with an EV/FCF ratio of 16.81.

EV / Earnings	34.42
EV / Sales	5.69
EV / EBITDA	31.96
EV / EBIT	40.69
EV / FCF	16.81

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.05.

Current Ratio	1.56
Quick Ratio	1.47
Debt / Equity	0.05
Debt / EBITDA	0.27
Debt / FCF	0.14
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 19.10% and return on invested capital (ROIC) is 860.29%.

Return on Equity (ROE)	19.10%
Return on Assets (ROA)	5.10%
Return on Invested Capital (ROIC)	860.29%
Return on Capital Employed (ROCE)	11.68%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	347,157
Profits Per Employee	57,164
Employee Count	1,167
Asset Turnover	0.58
Inventory Turnover	9.09

Taxes

In the past 12 months, Cellebrite DI has paid 10.52 million in taxes.

Income Tax	10.52M
Effective Tax Rate	13.62%

Stock Price Statistics

The stock price has decreased by -40.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.63%
50-Day Moving Average	13.88
200-Day Moving Average	14.52
Relative Strength Index (RSI)	38.16
Average Volume (20 Days)	45

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.46

Income Statement

In the last 12 months, Cellebrite DI had revenue of EUR 405.13 million and earned 66.71 million in profits. Earnings per share was 0.26.

Revenue	405.13M
Gross Profit	341.11M
Operating Income	56.62M
Pretax Income	77.23M
Net Income	66.71M
EBITDA	66.73M
EBIT	56.62M
Earnings Per Share (EPS)	0.26

Balance Sheet

The company has 372.24 million in cash and 19.31 million in debt, with a net cash position of 436.36 million.

Cash & Cash Equivalents	372.24M
Total Debt	19.31M
Net Cash	436.36M
Net Cash Per Share	n/a
Equity (Book Value)	412.49M
Book Value Per Share	1.68
Working Capital	175.61M

Cash Flow

In the last 12 months, operating cash flow was 147.81 million and capital expenditures -11.26 million, giving a free cash flow of 136.54 million.

Operating Cash Flow	147.81M
Capital Expenditures	-11.26M
Free Cash Flow	136.54M
FCF Per Share	n/a

Margins

Gross margin is 84.20%, with operating and profit margins of 13.98% and 16.47%.

Gross Margin	84.20%
Operating Margin	13.98%
Pretax Margin	19.06%
Profit Margin	16.47%
EBITDA Margin	16.47%
EBIT Margin	13.98%
FCF Margin	33.70%

Dividends & Yields

Cellebrite DI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.30%
Shareholder Yield	-19.30%
Earnings Yield	2.44%
FCF Yield	5.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellebrite DI has an Altman Z-Score of 6.52 and a Piotroski F-Score of 4.

Altman Z-Score	6.52
Piotroski F-Score	4